Seattle Genetics (SGEN) Reports Q1 Loss of $0.73

Seattle Genetics (NASDAQ: SGEN) reported Q1 EPS of ($0.73), versus ($0.42) reported last year. Revenue for the quarter came in at $140.59 million, versus $109.13 million reported last year.

For earnings history and earnings-related data on Seattle Genetics (SGEN) click here.

You May Also Be Interested In

• Rivian reports record Q3 deliveries, beats estimates, shares rise
• Cantor Fitzgerald on Rivian (RIVN): 'pre-announced that it delivered 19,248 vehicles in 3Q26, above our estimate'
• First Watch (FWRG) PT Lowered to $15 at DA Davidson, Buy Rating Maintained